Edgardo Alania/Secardiologia.es
Sep 4, 2026, 02:18
Edgardo Alania: Edoxaban in Intracranial Haemorrhage Survivors with AF
Edgardo Alania, Cardiologist at Hospital Marina Salud (Denia), shared a post on X:
“ENRICH-AF (n is equal to 948): Edoxaban after intracranial haemorrhage did not reduce stroke or systemic embolism (11.8% vs 12.8%; HR 0.88) but increased major bleeding (11.6% vs 5.2%; HR 2.23).
Routine edoxaban is not supported in this unselected population.”
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 07:59Leila Caroline Souza Reis: Enoxaparin Dosing for VTE Prevention in Adults With Obesity
-
Oct 10, 2026, 07:41Adeeb Bazuhair: New Evidence for Catheter Directed Thrombolysis in Acute PE
-
Oct 10, 2026, 07:22Poppy Clarke: Turning Steps Into Support for Thrombosis Awareness
-
Oct 10, 2026, 07:12Hamzah Khan: The Role of Genuine Curiosity in Driving High-Impact Academic Research
-
Oct 10, 2026, 06:58Nita Radhakrishnan: Turning Evidence Into Action for Hemophilia Care in India
-
Oct 10, 2026, 06:48Nutan Kaushik: HemeNext 2.0 Brings Global Perspectives to Hematology
-
Oct 10, 2026, 06:43Suthesh Sivapalaratnam: Advancing Bleeding Disorder Care at EHC 2026
-
Oct 10, 2026, 02:38Brianne D.: Sex Differences in RIPK1 Signaling Following Intracerebral Hemorrhage
-
Oct 10, 2026, 02:17Dino Mehic: Managing Heavy Menstrual Bleeding in Patients with BDUC